Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexycu for dry eye after cataract surgery
NCT04184999Phase 4Completed
- Sponsor
- SR Cornea Consultants
- Start
- Aug 2019
- Primary completion
- Dec 2019
- Modality
- Small Molecules, Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of dexamethasone iontophoretic patch in dry eye syndrome (DED) (2 arms), sponsored by SR Cornea Consultants. Primary endpoint: Tear Film Osmolarity at 3 weeks. Started Aug 2019; status: completed.
02
Drugs
dexamethasone iontophoretic patch
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT04184999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04184999.